Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis × Surveys and Questionnaires × Plasma cell × Clear all

NCT00651937 2020-01-14

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Phase 2 Completed

80 enrolled 7 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma